Showing results (71-80 of 106) with videos related to

Sort By:
Pageof 11
Assay and Drug Development Technologies|August 20, 2009
Evaluation of alpha7 nicotinic acetylcholine receptor agonists and positive allosteric modulators using the parallel oocyte electrophysiology test stationJohn Malysz, Jens H Grønlien, Daniel B Timmermann, et al.
Bioorganic & Medicinal Chemistry Letters|December 29, 2005
Structure-activity relationships of alpha-amino acid ligands for the alpha2delta subunit of voltage-gated calcium channelsKathleen H Mortell, David J Anderson, James J Lynch, et al.
Journal of Neuroimmunology|September 14, 2011
Role of α7 nicotinic acetylcholine receptors in regulating tumor necrosis factor-α (TNF-α) as revealed by subtype selective agonistsJinhe Li, Suzanne L Mathieu, Richard Harris, et al.
Bioorganic & Medicinal Chemistry|March 31, 2004
Structure-activity studies for a novel series of tricyclic dihydropyridopyrazolones and dihydropyridoisoxazolones as K(ATP) channel openersIrene Drizin, Robert J Altenbach, Steven A Buckner, et al.
The Journal of Pharmacology and Experimental Therapeutics|September 2, 2004
Pentamidine-induced long QT syndrome and block of hERG traffickingYuri A Kuryshev, Eckhard Ficker, Lu Wang, et al.
Bioorganic & Medicinal Chemistry Letters|May 6, 2003
Characterization of HERG potassium channel inhibition using CoMSiA 3D QSAR and homology modeling approachesRobert A Pearlstein, Roy J Vaz, Jiesheng Kang, et al.
Bioorganic & Medicinal Chemistry Letters|December 31, 2003
Design and synthesis of novel cyanoguanidine ATP-sensitive potassium channel openers for the treatment of overactive bladderArturo Perez-Medrano, Steven A Buckner, Michael J Coghlan, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2004
Synthesis and SAR of novel 4,5-diarylimidazolines as potent P2X7 receptor antagonistsGregory H Merriman, Liang Ma, Patrick Shum, et al.
Pageof 11